Rankings
▼
Calendar
MRVI Q2 2020 Earnings — Maravai LifeSciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena
MRVI
Maravai LifeSciences Holdings, Inc.
$970M
Q2 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$47M
Gross Profit
$26M
54.8% margin
Operating Income
$8M
17.3% margin
Net Income
$207,000
0.4% margin
EPS (Diluted)
$0.00
QoQ Revenue Growth
-8.0%
Cash Flow
Operating Cash Flow
$12M
Free Cash Flow
$9M
Stock-Based Comp.
$576,000
← FY 2020
All Quarters
Q3 2020 →
